Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

NCT04408586 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Phentermine-Topiramate Extended Release
DRUG: Placebo
OTHER: Online support system

Sponsor

Mayo Clinic